Interventional Cardiology Resource Center Editorial Programs

 
 
  • Life and Times of Leading Cardiologists: John Simpson   Interviewee Dr John Simpson failed as a bank teller after losing Jack Nicklaus's US Open winnings but went on to invent the first over-the-balloon catheter and other interventional cardiology devices.
  • Refractory Angina: Two Challenging Cases   Dr Sandhu illustrates strategies for diagnosing and treating intractable angina using two complex case studies in a discussion with Dr Widmer.
  • PCI vs CABG: A Surgeon and Interventionalist Discussion   Surgeon Dr Kappetein and interventional cardiologist Dr Pyo discuss the various indications for PCI vs CABG, and their preferred revascularization strategy for different types of patients.
  • Cardiovascular Safety of Nonsteroidal Anti-inflammatory Drugs Drs Elgendy and Bavry review the data on cardiovascular safety of nonsteroidal anti-inflammatory drugs, and outline the knowns and unknowns.
  • AUGMENT-HF: A Novel Approach to Cardiac Remodeling   Dr Ileana Piña sits down with Dr Douglas Mann to talk about cardiac remodeling and data from the AUGMENT-HF trial on a novel injectable gel.
  • Three Must-Read Emergency Medicine Articles of 2015 Dr Amal Mattu makes his picks for the most interesting emergency medicine literature of the past year.
  • The Physician's Role in Patient Decision-Making   Dr Moat leads a panel discussion on the delicate art of helping patients make treatment decisions when there is some uncertainty about the best strategy.
  • Mandrola's Top 10 Cardiology Stories 2015 In what is becoming an annual tradition, Dr John Mandrola reviews his top 10 stories of 2015 in the field of cardiovascular medicine.
  • CMS Proposal on Watchman Is the Right Decision The Watchman left atrial appendage closure device had a rocky road to FDA approval, but a CMS proposal could place new limitations on its use, which would be a good thing, according to Dr John Mandrola.
  • The Cardiology Show From AHA 2015 With Dr Valentin Fuster   The SPRINT hypertension trial tops a show that also covers in-ambulance troponin testing, repair vs replace for ischemic mitral regurgitation, peer counseling to reduce CV risk factors, and four runners-up trials.
  • AHA Ticagrelor and Science: Is the Dyspnea Really Worth It? Dr Melissa Walton-Shirley reports on the presentation about the long-term tolerability of ticagrelor in PEGASUS vs the results of her experience with the drug.
  • AHA AHA 2015 Scientific Sessions Previewed by John Mandrola Dr John Mandrola peruses the program for the upcoming American Heart Association Scientific Sessions in Orlando and outlines the studies he'll be looking out for.
  • FFR-CT Angiography: The PROMISE of PLATFORM   Dr Harrington interviews Dr Douglas about the PLATFORM trial on FFR-CT angiography and the use of noninvasive functional testing to reduce inappropriate cardiac catheterizations.
  • A Low-Tech Approach to AKI Prevention A new study shows how the blood pressure cuff may assist in providing robust protection against bypass surgery-related ischemic AKI.
  • ESC Interventional Cardiology Highlights   Drs Fox and Stone review late-breaking data on bioresorbable stents, FFRCT, and bivalirudin from the European Society of Cardiology Congress.
  • LEADLESS II: Dr Vivek Reddy Interviewed   From ESC, Dr Mandrola interviews Dr Reddy about the single-chamber leadless pacemaker that doesn't require a subcutaneous pocket.
  • The Cardiology Show From ESC 2015 with Dr Valentin Fuster   UPDATED with Transcript // The panel discuss a leadless pacemaker, cyclosporine and reperfusion injury, hypertension treatments, high-sensitivity troponin for early MI diagnosis, and yet more data on antithrombins for PCI.
  • ESC One-Liners From ESC 2015 Day 1 Dr Melissa Walton-Shirley zips through the take-home messages of 23 presentations.
  • ESC TAVI: A Solution for All Patients: A Pro-Con Debate at ESC 2015 Dr John Mandrola reports on a debate centered on who should undergo TAVI vs surgical aortic-valve replacement as well as one on whether very high-risk patients should receive the procedure.
  • Seeing Every Patient Encounter as a Research Opportunity   Dr Harrington interviews HEAT-PPCI principal investigator Dr Rod Stables about engaging the hospital community in research and the benefits for all concerned.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.